FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553301423> ?p ?o ?g. }

• W2553301423 endingPage "130" @default.
• W2553301423 startingPage "130.2" @default.
• W2553301423 abstract "<h3>Background</h3> Biotherapies prescribed in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) are associated with risks that patients must be aware of. Patient education offers them to learn how to manage such treatments on a day-to-day basis. In our department, patients can benefit from 3 different educational models: individual informational consultation (Model 1), individual consultations including the 4 recommended steps (educational diagnosis, objectives, education and assessment) (Model 2) and individual consultations with group workshops (Model 3). <h3>Objectives</h3> To assess which educational model appears the most appropriate for maintaining optimal safety in the self-management of biotherapy. <h3>Methods</h3> This is an observational, monocentric, retrospective study on routine care. All patients on biotherapy with at least one educational consultation between 2009 and 2013 were subsequently divided up according to the undergone educational model (Models 1, 2, or 3). During normal management, patients filled out the BIOSECURE questionnaire, meant to assess their theoretical and practical knowledge (clinical cases), prior to consultation with an education nurse. The overall BIOSECURE score, its theoretical and practical subsections, the different dimensions of the questionnaire and the behaviors in risk situations were compared based on the 3 models. <h3>Results</h3> In total, 222 patients were included (67% women, age 53.9 years, disease duration: 10 years, RA n=137, SpA n=77 and uncategorized rheumatism n=8, anti-TNF 89.6%, rituximab 3.2%, abatacept 3.6%, and tocilizumab 3.6%. As regards the educational model, 106 patients (47.8%) benefited from Model 1, 88 (39.6%) from Model 2, and 28 (12.6%) from Model 3. The overall BIOSECURE score was 76.6/100 without any significant difference depending upon the educational model (Model 1: 75.1, Model 2: 76.7, Model 3: 81.8; p=0.07). The BIOSECURE score was significantly higher amongst women (p=0.007), young people (p<0.001), working patients (p=0.005), higher education degree holders (p<0.001), patients whose diagnosis was most recent (p=0.008), as well as patients on etanercept (p=0.04) and those on intravenous biotherapies (p=0.004). Model 3 patients displayed a significantly higher practical score (clinical cases) than Model 1 (p<0.001) and 2 (p=0.003) patients. There was also a significant difference in BIOSECURE score in favor of Model 3 in certain skill areas, such as “Patient behavior in case of fever” (p=0.03) and “Behavior when faced with injuries, prevention of infectious complications and vaccination” (p=0.03). In terms of the implementation of acquired knowledge in risk situations, 64.5% of patients displayed appropriate behavior in the event of signs of infection, 68% in the case of surgical intervention, and 65% in the event of dental avulsion, without anydifference depending upon the model. <h3>Conclusions</h3> The educational model involving group workshops showed no significant variation from the overall BIOSECURE score amongst patients treated with a biotherapy for RA or SpA when compared to the models based solely on individual consultations. However, patients having participated in group workshops exhibited improvement in practical scores and certain skill areas. <h3>Disclosure of Interest</h3> None declared" @default.
• W2553301423 created "2016-11-30" @default.
• W2553301423 creator A5003211967 @default.
• W2553301423 creator A5012917558 @default.
• W2553301423 creator A5013394355 @default.
• W2553301423 creator A5025379642 @default.
• W2553301423 creator A5036693850 @default.
• W2553301423 creator A5078962277 @default.
• W2553301423 date "2016-06-01" @default.
• W2553301423 modified "2023-09-24" @default.
• W2553301423 title "OP0195-HPR Comparison of Educational Models for Maintaining Optimal Safety in The Self-Management of Biotherapy amongst Rheumatoid Arthritis and Spondyloarthritis Patients" @default.
• W2553301423 doi "https://doi.org/10.1136/annrheumdis-2016-eular.2349" @default.
• W2553301423 hasPublicationYear "2016" @default.
• W2553301423 type Work @default.
• W2553301423 sameAs 2553301423 @default.
• W2553301423 citedByCount "0" @default.
• W2553301423 crossrefType "journal-article" @default.
• W2553301423 hasAuthorship W2553301423A5003211967 @default.
• W2553301423 hasAuthorship W2553301423A5012917558 @default.
• W2553301423 hasAuthorship W2553301423A5013394355 @default.
• W2553301423 hasAuthorship W2553301423A5025379642 @default.
• W2553301423 hasAuthorship W2553301423A5036693850 @default.
• W2553301423 hasAuthorship W2553301423A5078962277 @default.
• W2553301423 hasConcept C126322002 @default.
• W2553301423 hasConcept C167135981 @default.
• W2553301423 hasConcept C1862650 @default.
• W2553301423 hasConcept C23131810 @default.
• W2553301423 hasConcept C2777178219 @default.
• W2553301423 hasConcept C2777575956 @default.
• W2553301423 hasConcept C2777929519 @default.
• W2553301423 hasConcept C2779338263 @default.
• W2553301423 hasConcept C2779605438 @default.
• W2553301423 hasConcept C2780653079 @default.
• W2553301423 hasConcept C512399662 @default.
• W2553301423 hasConcept C71924100 @default.
• W2553301423 hasConceptScore W2553301423C126322002 @default.
• W2553301423 hasConceptScore W2553301423C167135981 @default.
• W2553301423 hasConceptScore W2553301423C1862650 @default.
• W2553301423 hasConceptScore W2553301423C23131810 @default.
• W2553301423 hasConceptScore W2553301423C2777178219 @default.
• W2553301423 hasConceptScore W2553301423C2777575956 @default.
• W2553301423 hasConceptScore W2553301423C2777929519 @default.
• W2553301423 hasConceptScore W2553301423C2779338263 @default.
• W2553301423 hasConceptScore W2553301423C2779605438 @default.
• W2553301423 hasConceptScore W2553301423C2780653079 @default.
• W2553301423 hasConceptScore W2553301423C512399662 @default.
• W2553301423 hasConceptScore W2553301423C71924100 @default.
• W2553301423 hasIssue "Suppl 2" @default.
• W2553301423 hasLocation W25533014231 @default.
• W2553301423 hasOpenAccess W2553301423 @default.
• W2553301423 hasPrimaryLocation W25533014231 @default.
• W2553301423 hasRelatedWork W143916602 @default.
• W2553301423 hasRelatedWork W1979392798 @default.
• W2553301423 hasRelatedWork W2062697678 @default.
• W2553301423 hasRelatedWork W2100678780 @default.
• W2553301423 hasRelatedWork W2901546121 @default.
• W2553301423 hasRelatedWork W2902184252 @default.
• W2553301423 hasRelatedWork W2918206885 @default.
• W2553301423 hasRelatedWork W3160874207 @default.
• W2553301423 hasRelatedWork W3197965981 @default.
• W2553301423 hasRelatedWork W2341212936 @default.
• W2553301423 hasVolume "75" @default.
• W2553301423 isParatext "false" @default.
• W2553301423 isRetracted "false" @default.
• W2553301423 magId "2553301423" @default.
• W2553301423 workType "article" @default.